return to CNTN

    Publications | Abstracts

Fields JA, Metcalf J, Overk C, Adame A, Spencer B, Wrasidlo W, Florio J, Rockenstein E, He JJ, Masliah E.  (2017). The anticancer drug sunitinib promotes autophagy and protects from neurotoxicity in an HIV-1 Tat Model of neurodegeneration. Journal of Neurovirology, Epub. Jan. 19. PMID: 28105557  
Levine AJ, Quach A, Moore DJ, Achim CL, Soontornniyomkij V, Masliah E, Singer EJ, Gelman B, Nemanim N, Horvath S.  (2016). Accelerated epigenetic aging in brain is associated with pre-mortem HIV-associated neurocognitive disorders. Journal of Neurovirology, 22(3), 366-375. PMID: 26689571  PMCID: PMC4900944  
Joseph J, Cinque P, Colosi D, Dravid A, Ene L, Fox H, Gabuzda D, Gisslen M, Beth J, Letendre S, Mukerji SS, Nath A, Perez-Valero I, Persaud D, Price RW, Rao VR, Sacktor N, Swanstrom R, Winston A, Wojna V, Wright E, Spudich S.  (2016). Highlights of the global HIV-1 CSF Escape Consortium Meeting, 9 June 2016, Bethesda, MD, USA. Journal of Virus Eradication, 2(4), 243-250. PMID: 27781109  PMCID: PMC5075354  
Soontornniyomkij V, Umlauf A, Soontornniyomkij B, Batki IB, Moore DJ, Masliah E, Achim CL.  (2016). Lifetime Methamphetamine dependence is associated with cerebral microgliosis in HIV-1-infected adults. Journal of Neurovirology, 22(5), 650-660. PMID: 27098516  PMCID: PMC5055415  
Var SR, Day TRC, Vitomirov A, Smith DM, Soontornniyomkij V, Moore DJ, Achim CL, Mehta SR, Perez-Santiago J.  (2016). Mitochondrial injury and cognitive function in HIV infection and methamphetamine use. AIDS (London, England), 30(6), 839-848. PMID: 26807965  PMCID: PMC475088  
Levine AJ, Soontornniyomkij V, Achim CL, Masliah E, Gelman BB, Sinsheimer JS, Singer EJ, Moore DJ.  (2016). Multilevel analysis of neuropathogenesis of neurocognitive impairment in HIV. Journal of Neurovirology, 22(4), 431-444. PMID: 26637429  PMCID: PMC4893344  
Fields JA, Overk C, Adame A, Florio J, Mante M, Pineda A, Desplats P, Rockenstein E, Achim C, Masliah E.  (2016). Neuroprotective effects of the immunomodulatory drug FK506 in a model of HIV1-gp120 neurotoxicity. Journal of Neuroinflammation, 13(1), 120. PMID: 27220536  PMCID: PMC4879748  
Marquine MJ, Montoya JL, Umlauf A, Fazeli PL, Gouaux B, Heaton RK, Ellis RJ, Letendre SL, Grant I, Moore DJ, and the HNRP Group.  (2016). The Veterans Aging Cohort Study (VACS) Index and neurocognitive change: A longitudinal study. Clinical Infectious Diseases : An Official Publication of The Infectious Diseases Society of America, 63(5), 694-702. PMID: 27199461  PMCID: PMC4981756  
Bryant AK, Ellis RJ, Umlauf A, Gouaux B, Soontornniyomkij V, Letendre SL, Achim CL, Masliah E, Grant I, Moore DJ.  (2015). Antiretroviral therapy reduces neurodegeneration in HIV infection. AIDS (London, England), 29(3), 323-30. PMID: 25686681  PMCID: PMC4353640  
Fields J, Dumaop W, Elueteri S, Campos S, Serger E, Trejo M, Kosberg K, Adame A, Spencer B, Rockenstein E, He J, Masliah E.  (2015). HIV-1 Tat alters neuronal autophagy by modulating autophagosome fusion to the lysosome: Implications for HIV-associated neurocognitive disorders. The Journal of Neuroscience : The Official Journal of The Society for Neuroscience, 35(5), 1921-38. PMID: 25653352  PMCID: PMC4315828  
Fields JA, Dumaop W, Crews L, Adame A, Spencer B, Metcalf J, He J, Rockenstein E, Masliah E.  (2015). Mechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: Role in HIV-associated neurocognitive disorders. Current HIV Research, 13(1), 43-54. PMID: 25760044  PMCID: PMC4455959  
Thames AD, Briones MS, Magpantay LI, Martinez-Maza O, Singer EJ, Hinkin CH, Morgello S, Gelman B B, Moore DJ, Heizerling K, Levine AJ.  (2015). The role of chemokine C-C motif ligand 2 genotype and cerebrospinal fluid chemokine C-C motif ligand 2 in neurocognition among HIV-infected patients. AIDS (London, England), 29(12), 1483-91. PMID: 26244388  PMCID: PMC4573552  
Tatro ET, Soontornniyomkij B, Letendre SL, Achim CL.  (2014). Cytokine secretion from brain macrophages infected with Human Immunodeficiency Virus in vitro and treated with raltegravir. BMC Infectious Diseases, 14(1), 386. PMID: 25015002  PMCID: PMC4227040  
Desplats P, Dumaop W, Cronin P, Gianella S, Woods S, Letendre S, Smith D, Masliah E, Grant I.  (2014). Epigenetic alterations in the brain associated with HIV-1 infection and methamphetamine dependence. PloS One, 9(7), e102555. PMID: 25054922  PMCID: PMC4108358  
Soontornniyomkij V, Umlauf A, Chung SA, Cochran ML, Soontornniyomkij B, Gouaux B, Toperoff W, Moore DJ, Masliah E, Ellis RJ, Grant I, Achim CL.  (2014). HIV protease inhibitor exposure predicts cerebral small vessel disease. AIDS (London, England), 28(9), 1297-1306. PMID: 24637542  PMCID: PMC4071161  
Marquine MJ, Umlauf A, Rooney A, Fazeli P, Gouaux B, Woods SP, Letendre SL, Ellis RJ, Grant I, Moore DJ and the HNRP Group.  (2014). The Veterans Aging Cohort Study (VACS) Index is associated with concurrent risk for neurocognitive impairment. Journal of Acquired Immune Deficiency Syndromes, 65(2), 190-197. PMID: 24442225  PMCID: PMC3907119  
Marcotte TD, Deutsch R, Michael BD, Franklin D, Cookson Rosario D, Bharti A, Grant I, Letendre SL.  (2013). A concise panel of biomarkers identifies neurocognitive functioning changes in HIV-infected individuals. Journal of Neuroimmune Pharmacology : The Official Journal of The Society On NeuroImmune Pharmacology, 8(5), 1123-1135. PMID: 24101401  PMCID: PMC3874146  
Bandaru VVR, Mielke MM, Sacktor N, McArthur JC, Grant I, Letendre S, Chang L, Wojna V, Pardo C, Calabresi P, Munsaka S, Haughey NJ.  (2013). A lipid storage-like disorder contributes to cognitive decline in HIV-infected subjects. Neurology, 81(17), 1492-1499. PMID: 24027056  PMCID: PMC3888167  
Fields J, Dumaop W, Rockenstein E, Mante M, Spencer B, Grant I, Ellis R, Letendre S, Patrick C, Adame A, Masliah E.  (2013). Age-dependent molecular alterations in the autophagy pathway in HIVE patients and in a gp120 tg mouse model: reversal with beclin-1 gene transfer. Journal of NeuroVirology, 19(1), 89-101. PMID: 23341224  PMCID: PMC3567331  
Fields J, Dumaop W, Adame A, Ellis RJ, Letendre S, Grant I, Masliah E.  (2013). Alterations in the levels of vesicular trafficking proteins involved in HIV replication in the brains and CSF of patients with HIV-associated neurocognitive disorders. Journal of Neuroimmune Pharmacology : The Official Journal of The Society On NeuroImmune Pharmacology, 8(5), 1197-209. PMID: 24292993  PMCID: PMC3973444  
Joseph J, Achim CL, Boivin MJ, Brew BJ, Clifford DB, Colosi DA, Ellis RJ, Heaton RK, Gallo-Diop A, Grant I, Kanmogne GD, Kumar M, Letendre S, Marcotte TD, Nath A, Pardo CA, Paul RH, Pulliam L, Robertson K, Royal W, Sacktor N, Sithinamsuwan P, Smith DM, Valcour V, Wigdahl B, Wood C.  (2013). Global NeuroAIDS Roundtable. Journal of NeuroVirology, 19(1), 1-9. PMID: 23354550  PMCID: PMC3713197  
Tatro ET, Hefler S, Shumaker-Armstrong S, Soontornniyomkij B, Yang M, Yermanos A, Wren N, Moore DJ, Achim CL.  (2013). Modulation of BK channel by MicroRNA-9 in neurons after exposure to HIV and Methamphetamine. Journal of Neuroimmune Pharmacology : The Official Journal of The Society On NeuroImmune Pharmacology, 8(5), 1210-1223. PMID: 23508624  PMCID: PMC3715589  
Desplats PA, Dumaop W, Smith DM, Adame A, Everall I, Letendre S, Ellis RJ, Cherner M, Grant I, Masliah E.  (2013). Molecular and pathologic insights from latent HIV-1 infection in the human brain. Neurology, 80(15), 1415-1423. PMID: 23486877  PMCID: PMC3662272  
Gelman BB, Lisinicchia JG, Morgello S, Masliah E, Commins D, Achim CL, Fox HS, Kolson DL, Grant I, Singer E, Yiannoutsos CT, Sherman S, Gensler G, Moore DJ, Chen T, Soukup VM.  (2013). Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort. Journal of Acquired Immune Deficiency Syndromes, 62(5), 487-495. PMID: 23242157  PMCID: PMC3664102  
Levine A, Miller J, Shapshak P, Gelman B, Singer E, Hunkin C, Commins D, Morgello S, Grant I, Horvath S.  (2013). Systems analysis of human brain expression: Mechanisms for HIV-associated neurocognitive impairment and common pathways with Alzheimer's Disease. BMC Medical Genomics, 6(1), 4. PMID: 23406646  PMCID: PMC3626801  
Soontornniyomkij V, Soontornniyomkij B, Moore DJ, Gouaux B, Masliah E, Tung S, Vinters HV, Grant I, Achim CL.  (2012). Antioxidant Sestrin-2 redistribution to neuronal soma in human immunodeficiency virus-associated neurocognitive disorders. Journal of Neuroimmune Pharmacology, 7(3), 579-590. PMID: 22450766  PMCID: PMC3573843  
Soontornniyomkij V, Moore DJ, Gouaux B, Soontornniyomkij B, Tatro ET, Umlauf A, Masliah E, Levine AJ, Singer EJ, Vinters HV, Gelman BB, Morgello S, Cherner M, Grant I, Achim CL.  (2012). Cerebral β-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ε4 carriers. AIDS (London, England), 26(18), 2327-2335. PMID: 23018443  PMCID: PMC3576852  
Soontornniyomkij V, Everall IP, Moore DJ, Gouaux B, Tatro ET, Gospodarev V, Masliah E, Yin NS, Vinters HV, Achim CL.  (2012). Increased cortical expression of FK506 binding protein-51 in HIV-associated neurocognitive disorders. Journal of NeuroVirology, 18(4), 313-322. PMID: 22234543  PMCID: PMC3374917  
Croteau D, Best BM, Letendre S, Rossi SS, Ellis RJ, Clifford DB, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Morgello S, Grant I, and the CHARTER Group.  (2012). Lower than expected maraviroc concentrations in cerebrospinal fluid exceed the wild-type CCR5-tropic HIV-1 50% inhibitory concentration. AIDS, 26(7), 890-893. PMID: 22313954  PMCID: PMC3454507  
Kamat A, Lyons JL, Misra V, Uno H, Morgello S, Singer EJ, Gabuzda D.  (2012). Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection. Basic and Translational Science, 60(3), 234-243. PMID: 22569268  PMCID: PMC3383928  
Robinson-Papp J, Gelman BB, Grant I, Singer E, Gensler G, Morgello S, for the National NeuroAIDS Tissue Consortium.  (2012). Substance abuse increases the risk of neuropathy in an HIV-infected cohort. Muscle & Nerve, 45(4), 471-476. PMID: 22431078  PMCID: PMC331307  
Gelman BB, Chen T, Lisinicchia JG, Soukup VM, Carmical JR, Starkey JM, Masliah E, Commins DL, Brandt D, Grant I, Singer EJ, Levine AJ, Miller J, Winkler JM, Fox HS, Luxon BA.  (2012). The National NeuroAIDS Tissue Consortium Brain Gene Array: Two types of HIV-associated neurocognitive impairment. PloS One, 7(9), e46178. PMID: 23049970  PMCID: PMC3458860  
Croteau D, Letendre S, Best BM, Rossi SS, Ellis RJ, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur J, McCutchan JA, Morgello S, Simpson DM, Way L, Capparelli E, Grant I; and the CHARTER Group.  (2012). Therapeutic amprenavir concentrations in cerebrospinal fluid. Antimicrobial Agents and Chemotherapy, 56(4), 1985-89. PMID: 22290964  PMCID: PMC3318381  
Zhou D, Masliah E, Spector SA.  (2011). Autophagy is increased in postmortem brains of persons with HIV-1-associated encephalitis. The Journal of Infectious Diseases, 203(11), 1647-57. PMID: 21592995  PMCID: PMC3096793  
Letendre SL, Zheng JC, Kaul M, Yiannoutsos CT, Ellis RJ, Taylor MJ, Marquie-Beck J, Navia B, for the HIV Neuroimaging Consortium.  (2011). Chemokines in cerebrospinal fluid correlate with cerebral metabolite patterns in HIV-infected individuals. Journal of NeuroVirology, 17(1), 63-69. PMID: 21246320  PMCID: PMC3032187  
Tate DF, Sampat M, Harezlak J, Fiecas M, Hogan J, Dewey J, McCaffrey D, Branson D, Russell T, Conley J, Taylor M, Schifitto G, Zhong J, Daar ES, Alger J, Brown M, Singer E, Campbell T, McMahon D, Tso Y, Matesan J, Letendre S, Paulose S, Gaugh Michelle, Tripoli C, Yiannoutsos C, Bigler ED, Cohen RA, Guttmann CR, Navia B.  (2011). Erratum to: Regional areas and widths of the midsagittal corpus callosum among HIV-infected patients on stable antiretroviral therapies. Journal of NeuroVirology, 17(4), 380-381. PMID: 21556960  
Singh KK, Nathamu S, Adame A, Alire TU, Dumaop W, Gouaux B, Moore DJ, Masliah E, and the HNRC Group.  (2011). Expression of Mannose Binding Lectin in HIV-1-infected brain: Implications for HIV-related neuronal damage and neuroAIDS. Neurobehavioral HIV Medicine, 3, 41-52. PMID: 21852898  PMCID: PMC3156486  
Patrick C, Crews L, Desplats P, Dumaop W, Rockenstein E, Achim CL, Everall IP, Masliah E.  (2011). Increased CDK5 expression in HIV encephalitis contributes to neurodegeneration via tau phosphorylation and is reversed with roscovitine. The American Journal of Pathology, 178(4), 1646-61. PMID: 21435449  PMCID: PMC3078446  
 Langford TD, Everall IP, Masliah E.  (2011). Neuronal Injury, White Matter Disease, and Neurotrophic Factors. In Gendelman HE, Grant I, Everall IP, Fox HS, Gelbard HA, Lipton SA, and Swindells S (Eds.), The Neurology of AIDS, 3rd edition. , (pp. 619-632). New York: Oxford University Press.
Jatiani A, Pannizzo P, Gualco E, Del-Valle L, Langford D.  (2011). Neuronal PINCH is regulated by TNF-α and is required for neurite extension. J Neuroimmune Pharmacol, 6(3), 330-340. PMID: 20689998  PMCID: PMC3107369  
Paulino AD, Ubhi K, Rockenstein E, Adame A, Crews L, Letendre S, Ellis R, Everall IP, Grant I, Masliah E.  (2011). Neurotoxic effects of the HCV core protein are mediated by sustained activation of ERK via TLR2 signaling. Journal of NeuroVirology, 17(4), 327-340. PMID: 21660601  PMCID: PMC3919659  
Harezlak J, Buchthal S, Taylor M, Schifitto G, Zhong J, Daar ES, Alger J, Singer E, Campbell T, Yiannoutsos C, Cohen R, Navia BA and the HIV Neuroimaging Consortium.  (2011). Persistence of HIV-associated cognitive impairment, inflammation and neuronal injury in the era of highly active antiretroviral treatment. AIDS, 25, 625-633. PMID: 21297425  
Crews L, Ruf R, Patrick C, Dumaop W, Trejo-Morales M, Achim CL, Rockenstein E, Masliah E.  (2011). Phosphorylation of collapsin response mediator protein-2 disrupts neuronal maturation in a model of adult neurogenesis: Implications for neurodegenerative disorders. Molecular Neurodegeneration, 6(1), 67. PMID: 21943307  PMCID: PMC3204248  
Lyons JL, Uno H, Ancuta P, Kamat A, Moore DJ, Singer EJ, Morgello S, Gabuzda D.  (2011). Plasma SCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection. Journal of Acquired Immune Deficiency Syndromes (1999), 57(5), 371-379. PMID: 21646912  PMCID: PMC3159710  
Tate DF, Sampat M, Harezlak J, Fiecas M, Hogan J, Dewey J, McCaffrey D, Branson D, Russell T, Conley J, Taylor M, Schifitto G, Zhong J, Daar ES, Alger J, Brown M, Singer E, Campbell T, McMahon D, Tso Y, Matesan J, Letendre S, Paulose S, Gaugh M, Tripoli C, Yiannoutsos C, Bigler ED, Cohen RA, Guttmann CR G, Navia B, and the HIV Neuroimaging Consortium.  (2011). Regional areas and widths of the midsagittal corpus callosum among HIV-infected patients on stable antiretroviral therapies. Journal of NeuroVirology, 17(4), 368-379. PMID: 21556960  
Cohen RA, Harezlak J, Gongvatana A, Buchthal S, Schifitto G, Clark U, Paul R, Taylor M, Thompson P, Tate D, Alger J, Brown M, Zhong J, Campbell T, Singer E, Daar E, McMahon D, Tso Y, Yiannoutsos CT, Navia B and the HIV Neuroimaging Consortium.  (2010). Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes. Journal of NeuroVirology, 16, 435-444. PMID: 20961212  
Tatro E, Nguyen TB, Bousman CA, Masliah E, Grant I, Atkinson JH, Everall IP.  (2010). Correlation of major depressive disorder symptoms with FKBP5 but not FKBP4 expression in HIV-infected individuals. Journal of NeuroVirology, 16(5), 399-404. PMID: 20726698  PMCID: PMC327449  
Cohen RA, Harezlak J, Schifitto G, Hana G, Clark U, Gonvatana A, Paul R, Taylor M, Thompson P, Alger J, Brown M, Zhong J, Campbell T, Singer E, Daar E, McMahon D, Tso Y, Yiannoutsos CT, Navia B.  (2010). Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era. Journal of NeuroVirology, 16, 25-32. PMID: 20113183  PMCID: PMC2995252  
Kang Y, Digicaylioglu M, Russo R, Kaul M, Achim CL, Fletcher L, Masliah E, Lipton SA.  (2010). Erythropoietin plus insulin-like growth factor-I protects against neuronal damage in a murine model of Human Immunodeficiency Virus-associated neurocognitive disorders. Annals of Neurology, 68(3), 342-52. PMID: 20818790  PMCID: PMC3733362  
Tatro ET, Scott ER, Nguyen TB, Salaria S, Banerjee S, Moore DJ, Masliah E, Achim C, Everall I.  (2010). Evidence for alteration of gene regulatory networks through microRNAs of the HIV-infected brain: novel analysis of retrospective cases. PLoS One, 5(4), e10337. PMID: 20436668  PMCID: PMC2859933  
Tan CS, Ellis LC, Wüthrich C, Ngo L, Broge TA Jr, Saint-Aubyn J, Miller JS, Koralnik IJ.  (2010). JC virus latency in the brain and extraneural organs of patients with and without progressive multifocal leukoencephalopathy. Journal of Virology, 84, 9200-9209. PMID: 20610709  PMCID: PMC2937633  
Kamat A, Ancuta P, Blumberg RS, Gabuzda D.  (2010). Serological markers for inflammatory bowel disease in AIDS patients with evidence of microbial translocation. PLoS One, 5, 1-8. PMID: 21125014  PMCID: PMC2981579  
Sidhu N, McCutchan JA.  (2010). Unmasking of PML by HAART: unusual clinical features and the role of IRIS. Journal of Neuroimmunology, 219(1-2), 100-104. PMID: 19962769  PMCID: PMC2825275  
Everall I, Vaida F, Khanlou N, Lazzaretto D, Achim C, Letendre SL, Moore D, Ellis R, Cherner M, Gelman B, Morgello S, Singer E, Grant I, Masliah E, and the National NeuroAIDS Tissue Consortium.  (2009). Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. Journal of NeuroVirology, 15(5-6), 360-370. PMID: 20175693  PMCID: PMC3078805  
Tan CS, Dezube BJ, Bhargava P, Autissier P, Wüthrich C, Miller J, Koralnik IJ.  (2009). Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation. Journal of Infectious Diseases, 199, 881-888. PMID: 19434914  PMCID: PMC2893283  
Tatro ET, Everall IP, Masliah E, Hult BJ, Lucero G, Chana G, Soontornniyomkij V, Achim CL, and the HNRC.  (2009). Differential expression of immunophilins FKBP51 and FKBP52 in the frontal cortex of HIV-infected patients with Major Depressive Disorder. Journal of Neuroimmune Pharmacology : The Official Journal of The Society On NeuroImmune Pharmacology, 4(2), 218-226. PMID: 19199039  PMCID: PMC2929573  
Achim CL, Adame A, Dumaop W, Everall IP, Masliah E, and the HNRC Group.  (2009). Increased accumulation of intraneuronal amyloid beta in HIV-infected patients. Journal of Neuroimmune Pharmacology : The Official Journal of The Society On NeuroImmune Pharmacology, 4(2), 190-199. PMID: 19288297  PMCID: PMC3055557  
Khanlou N, Moore DJ, Chana G, Cherner M, Lazzaretto D, Dawes S, Grant I, Masliah E, Everall I, and the HNRC Group.  (2009). Increased frequency of Alpha-synuclein in the substantia nigra in Human Immunodeficiency Virus infection. Journal of NeuroVirology, 15(2), 131-138. PMID: 19115126  PMCID: PMC3979854  
Grigorian A, Hurford R, Chao Y, Patrick C, Langford TD.  (2008). Alterations in the Notch4 pathway in cerebral endothelial cells by the HIV aspartyl protease inhibitor, nelfinavir. BMC Neuroscience, 9, 1-18. PMID: 18302767  PMCID: PMC2268698  
Mocchetti I, Bachis A, Masliah E.  (2008). Chemokine receptors and neurotrophic factors: potential therapy against AIDS dementia. Journal of Neuroscience Research, 86(2), 243-55. PMID: 17847079  
Solbrig MV, Hasso AN, Jay CA.  (2008). CNS viruses--diagnostic approach. Neuroimaging Clinics of North America, 18, 1-18. PMID: 18319152  NIHMSID: 44196  
Norman JP, Perry SW, Reynolds HM, Kiebala M, De Mesy Bentley KL, Trejo M, Volsky DJ, Maggirwar SB, Dewhurst S, Masliah E, Gelbard HA.  (2008). HIV-1 Tat activates neuronal ryanodine receptors with rapid induction of the unfolded protein response and mitochondrial hyperpolarization. PLoS ONE, 3(11), e3731. PMID: 19009018  PMCID: PMC2579580  
Ancuta P, Kamat A, Kunstman KJ, Kim EY, Autissier P, Wurcel A, Zaman T, Stone D, Mefford M, Morgello S, Singer EJ, Wolinsky SM, Gabuzda D.  (2008). Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One, 3, 1-12. PMID: 18575590  PMCID: PMC2424175  
Crews L, Lentz MR, Gonzalez RG, Fox HS, Masliah E.  (2008). Neuronal injury in Simian Immunodeficiency Virus and other animal models of NeuroAIDS. Journal of NeuroVirology, 14(4), 327-39. PMID: 18780234  PMCID: PMC2562423  
Rearden A, Hurford R, Luu N, Kieu E, Sandoval M, Perez-Liz G, Del Valle L, Powell H, Langford TD.  (2008). Novel expression of PINCH in the central nervous system and its potential as a biomarker for human immunodeficiency virus-associated neurodegeneration. Journal of Neuroscience Research, 86, 2535-2542. PMID: 18459134  
Morgan EE, Woods SP, Scott JC, Childers M, Marquie Beck J, Ellis RJ, Grant I, Heaton RK, and the HNRC Group.  (2008). Predictive validity of demographically-adjusted normative standards for the HIV Dementia Scale. Journal of Clinical and Experimental Neuropsychology, 30(1), 83-90. PMID: 17852582  PMCID: PMC3659773  
Dawes S, Suarez P, Casey CY, Cherner M, Marcotte TD, Letendre S, Grant I, Heaton RK, and the HNRC Group.  (2008). Variable patterns of neuropsychological performance in HIV-1 infection. Journal of Clinical and Experimental Neuropsychology, 30(6), 613-626. PMID: 18608689  PMCID: PMC3092709  
Kuczenski R, Everall IP, Crews L, Adame A, Grant I, Masliah E.  (2007). Escalating dose-multiple binge methamphetamine exposure results in degeneration of the neocortex and limbic system in the rat. Experimental Neurology, 207(1), 42-51. PMID: 17603040  PMCID: PMC2796472  
Alirezaei M, Watry DD, Flynn CF, Kiosses WB, Masliah E, Williams BRG, Kaul M, Lipton SA, Fox HS.  (2007). Human Immunodeficiency Virus-1/surface Glycoprotein 120 induces apoptosis through RNA-activated protein kinase signaling in neurons. The Journal of Neuroscience : The Official Journal of The Society for Neuroscience, 27(41), 11047-55. PMID: 17928446  
Cherner M, Cysique L, Heaton RK, Marcotte TD, Ellis RJ, Masliah E, Grant I, and the HNRC Group.  (2007). Neuropathologic confirmation of definitional criteria for human immunodeficiency virus-associated neurocognitive disorders. Journal of NeuroVirology, 13(1), 23-28. PMID: 17454445  
Letendre S, Paulino AD, Rockenstein E, Adame A, Crews L, Cherner M, Heaton R, Ellis R, Everall IP, Grant I, Masliah E, and the HNRC Group.  (2007). Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. Journal of Infectious Diseases, 196(3), 361-370. PMID: 17597450  
Shimizu S, Khan MZ, Hippensteel RL, Parkar A, Raghupathi R, Meucci O.  (2007). Role of the transcription factor E2F1 in CXCR4-mediated neurotoxicity and HIV neuropathology. Neurobiology of Disease, 25, 17-26. PMID: 17011204  PMCID: PMC1762194  
Gongvatana A, Woods SP, Taylor MJ, Vigil O, Grant I, and the HNRC Group.  (2007). Semantic clustering inefficiency in HIV-associated dementia. Journal of Neuropsychiatry and Clinical Neurosciences, 19(1), 36-42. PMID: 17308225  
Woods SP, Childers M, Ellis RJ, Guaman S, Grant I, Heaton RK, and the HNRC Group.  (2006). A battery approach for measuring neuropsychological change. Archives of Clinical Neuropsychology, 21(1), 83-9. PMID: 16169705  
Woods SP, Morgan EE, Dawson M, Scott CJ, Grant I, and the HNRC Group.  (2006). Action (verb) fluency predicts dependence in instrumental activities of daily living in persons infected with HIV-1. Journal of Clinical and Experimental Neuropsychology, 28(6), 1030-42. PMID: 16822741  
Chana G, Everall IP, Crews L, Langford D, Adame A, Grant I, Cherner M, Lazzaretto D, Heaton R, Ellis R, Masliah E, and the HNRC Group.  (2006). Cognitive deficits and degeneration of interneurons in HIV+ methamphetamine users. Neurology, 67(8), 1486-9. PMID: 17060582  
Moore DJ, Masliah E, Rippeth JD, Gonzalez R, Carey CL, Cherner M, Ellis RJ, Achim CL, Marcotte TD, Heaton RK, Grant I, and the HNRC Group.  (2006). Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment. AIDS (London, England), 20(6), 879-87. PMID: 16549972  
Morgello S, Holzer CE, Ryan E, Young C, Naseer M, Castellon SA, Frol AB, Atkinson JH, Gelman BB, Grant I, Singer EJ.  (2006). Interrater reliability of the Psychiatric Research Interview for Substance and Mental Disorders in an HIV-infected cohort: experience of the National NeuroAIDS Tissue Consortium. International Journal of Methods in Psychiatric Research, 15(3), 131-8. PMID: 17019897  
Carey C, Woods SP, Rippeth JD, Heaton RK, Grant I, and the HNRC Group.  (2006). Prospective memory in HIV-1 infection. Journal of the International Neuropsychological Society, 28(4), 536-548. PMID: 16676475  PMCID: PMC1853378  
Langford D, Marquie-Beck J, de Almeida S, Lazzaretto D, Letendre S, Grant I, McCutchan JA, Masliah E, Ellis RJ.  (2006). Relationship of antiretroviral treatment to postmortem brain tissue viral load in Human Immunodeficiency Virus-infected patients. Journal of NeuroVirology, 12(2), 100-7. PMID: 16798671  
Patterson K, Young C, Woods SP, Vigil O, Grant I, Atkinson JH, and the HNRC Group.  (2006). Screening for major depression in persons with HIV infection: the concurrent predictive validity of the Profile of Mood States Depression-Dejection Scale. International Journal of Methods in Psychiatric Research, 15(2), 75-82. PMID: 19722288  
Woods SP, Scott JC, Sires DA, Grant I, Heaton RK, Troster AI, and the HNRC Group.  (2005). Action (verb) fluency: test-retest reliability, normative standards, and construct validity. Journal of the International Neuropsychological Society, 11, 408-415. PMID: 16209421  
Green DA, Masliah E, Vinters HV, Beizai P, Moore DJ, Achim CL.  (2005). Brain deposition of Beta-amyloid is a common pathologic feature in HIV positive patients. AIDS (London, England), 19(4), 407-11. PMID: 15750394  
Woods SP, Scott JC, Dawson MS, Morgan EE, Carey CL, Heaton RK, Grant I, and the HNRC Group.  (2005). Construct validity of Hopkins Verbal Learning Test-Revised component process measures in an HIV-1 sample. Archives of Clinical Neuropsychology : the official journal of the National Academy of Neuropsychologists, 20(8), 1061-71. PMID: 16198529  
Strain MC, Letendre S, Pillai SK, Russell T, Ignacio CC, Ganthard HF, Good B, Smith DM, Wolinsky SM, Furtado M, Marquie-Beck J, Durelle J, Grant I, Richman DD, Marcotte T, McCutchan JA, Ellis RJ, Wong JK.  (2005). Genetic composition of Human Immunodeficiency Virus Type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. Journal of Virology, 79(3), 1772-88. PMID: 15650202  PMCID: PMC544082  
Masliah E, Roberts ES, Langford D, Everall I, Crews L, Adame A, Rockenstein E, Fox HS.  (2005). Patterns of gene dysregulation in the frontal cortex of patients with HIV encephalitis. Journal of Neuroimmunology, 157(1-2), 163-75. PMID: 15579294  
Gelman BB, Soukup VM, Holzer CE 3rd, Fabian RH, Schuenke KW, Keherly MJ, Richey FJ, Lahart CJ.  (2005). Potential role for white matter lysosome expansion in HIV-associated dementia. Journal of Acquired Immune Deficiency Syndromes, 39, 422-425. PMID: 16010164  
Langford D, Hurford R, Hashimoto M, Digicaylioglu M, Masliah E.  (2005). Signalling crosstalk in FGF2-mediated protection of endothelial cells from HIV-gp120. BMC Neuroscience [electronic resource], 6(1), 8. PMID: 15689238  PMCID: PMC549045  
Bellizzi MJ, Lu SM, Masliah E, Gelbard HA.  (2005). Synaptic activity becomes excitotoxic in neurons exposed to elevated levels of platelet-activating factor. The Journal of Clinical Investigation, 115(11), 3185-92. PMID: 16276420  PMCID: PMC1265873  
Everall IP, Hansen LA, Masliah E.  (2005). The shifting patterns of HIV encephalitis neuropathology. Neurotoxicity Research, 8(1-2), 51-61. PMID: 16260385  
Langford D, Grigorian A, Hurford R, Adame A, Ellis RJ, Hansen L, Masliah E.  (2004). Altered P-glycoprotein expression in AIDS patients with HIV encephalitis. Journal of Neuropathology and Experimental Neurology, 63(10), 1038-47. PMID: 15535131  
Archibald SL, Masliah E, Fennema-Notestine C, Marcotte TD, Ellis RJ, McCutchan JA, Heaton RK, Grant I Mallory M, Miller A, Jernigan TL.  (2004). Correlation of in vivo neuroimaging abnormalities with postmortem Human Immunodeficiency Virus encephalitis and dendritic loss. Archives of Neurology, 61(3), 369-76. PMID: 15023814  
Carey C, Woods SP, Rippeth JD, Moore DJ, Gonzalez R, Marcotte TD, Grant I, Heaton RK, and the HNRC Group.  (2004). Initial validation of a screening battery for the detection of HIV-associated cognitive impairment. The Clinical Neuropsychologist, 18(2), 234-248. PMID: 15587671  
Woods SP, Rippeth JD, Frol AB, Levy JK, Ryan E, Soukup VM, Hinkin CH, Lazzaretto D, Cherner M, Marcotte TD, Gelman BB, Morgello S, Singer EJ, Grant I, Heaton RK.  (2004). Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. Journal of Clinical and Experimental Neuropsychology : official journal of the International Neuropsychological Society, 26(6), 759-78. PMID: 15370374  
Carlson KA, Limoges J, Pohlman GD, Poluektova LY, Langford D, Masliah E, Ikezu T, Gendelman HE.  (2004). OTK18 expression in brain mononuclear phagocytes parallels the severity of HIV-1 encephalitis. Journal of Neuroimmunology, 150(1-2), 186-98. PMID: 15081264  
Woods SP, Conover E, Rippeth JD, Carey CL, Gonzalez R, Marcotte TD, Heaton RK, Grant I, and the HNRC Group.  (2004). Qualitative aspects of verbal fluency in HIV-associated dementia: a deficit in rule-guided lexical-semantic search processes? Neuropsychologia, 42(6), 801-9. PMID: 15037058  
Langford D, Grigorian A, Hurford R, Adame A, Crews L, Masliah E.  (2004). The role of mitochondrial alterations in the combined toxic effects of Human Immunodeficiency Virus Tat protein and methamphetamine on calbindin positive-neurons. Journal of NeuroVirology, 10(6), 327-37. PMID: 15765804  
Woods SP, Conover E, Weinborn M, Rippeth JD, Brill RM, Heaton RK, Grant I, and the HNRC Group.  (2003). Base rate of Hiscock Digit Memory Test failure in HIV-associated neurocognitive disorders. The Clinical Neuropsychologist, 17(3), 383-9. PMID: 14704888  
Langford TD, Letendre SL, Larrea GJ, Masliah E.  (2003). Changing patterns in the neuropathogenesis of HIV during the HAART era. Brain Pathology (Zurich, Switzerland), 13(2), 195-210. PMID: 12744473  
Langford D, Adame A, Grigorian A, Grant I, McCutchan JA, Ellis RJ, Marcotte TD, Masliah E, and the HNRC Group.  (2003). Patterns of selective neuronal damage in methamphetamine-user AIDS patients. Journal of Acquired Immune Deficiency Syndromes, 34(5), 467-74. PMID: 14657756  
Samland H, Huitron-Resendiz S, Masliah E, Criado J, Henriksen SJ, Campbell IL.  (2003). Profound increase in sensitivity to glutamatergic- but not cholinergic agonist-induced seizures in transgenic mice with astrocyte production of IL-6. Journal of Neuroscience Research, 73(2), 176-87. PMID: 12836160  
Langford D, Sanders VJ, Mallory M, Kaul M, Masliah E.  (2002). Expression of stromal cell-derived factor 1 alpha protein in HIV encephalitis. Journal of Neuroimmunology, 127(1-2), 115-26. PMID: 12044982  
Hashimoto M, Sagara Y, Langford D, Everall IP, Mallory M, Everson A, Digicaylioglu M, Masliah E.  (2002). Fibroblast Growth Factor 1 regulates signaling via the glycogen synthase kinase-3beta pathway:implications for neuroprotection. The Journal of Biological Chemistry, 277(36), 32985-91. PMID: 12095987  
Everall IP, Bell C, Mallory M, Langford D, Adame A, Rockestein E, Masliah E.  (2002). Lithium ameliorates HIV-gp120-mediated neurotoxicity. Molecular and Cellular Neurosciences, 21(3), 493-501. PMID: 12498789  
Cherner M, Masliah E, Ellis RJ, Marcotte TD, Moore DJ, Grant I, Heaton RK, and the HNRC Group.  (2002). Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis. Neurology, 59(10), 1563-7. PMID: 12451198  
Langford D, Masliah E.  (2002). Role of trophic factors on neuroimmunity in neurodegenerative infectious diseases. Journal of NeuroVirology, 8(6), 625-38. PMID: 12476355  
Langford TD, Letendre SL, Marcotte TD, Ellis RJ, McCutchan JA, Grant I, Mallory ME, Hansen LA, Archibald S, Jernigan T, Masliah E, and the HNRC Group.  (2002). Severe demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy. AIDS, 16(7), 1019-1029. PMID: 11953468  
Everall IP, Trillo-Pazos G, Bell C, Mallory M, Sanders V, Masliah E.  (2001). Amelioration of neurotoxic effects of HIV envelope protein Gp120 by fibroblast growth factor: a strategy for neuroprotection. Journal of Neuropathology and Experimental Neurology, 60(3), 293-301. PMID: 11245213  
Langford D, Masliah E.  (2001). Crosstalk between components of the blood brain barrier and cells of the CNS in microglial activation in AIDS. Brain Pathology (Zurich, Switzerland), 11(3), 306-12. PMID: 11414473  
Morgello S, Gelman BB, Kozlowski PB, Vinters HV, Masliah E, Cornford M, Cavert W, Marra C, Grant I, Singer EJ.  (2001). The National NeuroAIDS Tissue Consortium: a new paradigm in brain banking with an emphasis on infectious disease. Neuropathology and Applied Neurobiology, 27, 326-335. PMID: 11532163  
Masliah E, de Teresa RM, Mallory ME, Hansen LA.  (2000). Changes in pathological findings at autopsy in AIDS cases for the last 15 years. AIDS (London, England), 14(1), 69-74. PMID: 10714569  
Sanders VJ, Everall IP, Johnson RW, Masliah E, and the HNRC Group.  (2000). Fibroblast growth factor modulates HIV coreceptor CXCR4 expression by neural cells. Journal of Neuroscience Research, 59(5), 671-9. PMID: 10686595